| Systematic (IUPAC) name | |
|---|---|
| 9-{3-[(3R,5S)-3,5-dimethylpiperazin-1-yl]propyl}-9H-carbazole | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 75859-04-0 |
| ATC code | None |
| PubChem | CID 53389 |
| UNII | C3N1PS8CX1 |
| ChEMBL | CHEMBL275707 |
| Chemical data | |
| Formula | C21H27N3 |
| Mol. mass | 321.459 |
| |
|
Rimcazole is an antagonist[1] of the sigma receptor[2] as well as a dopamine reuptake inhibitor[3]. Sigma receptors are thought to be involved in the drug psychosis that can be induced by some drugs such as PCP and cocaine, and rimcazole was originally researched as a potential antipsychotic with a different mechanism of action to traditional antipsychotic drugs. Trials proved inconclusive and rimcazole was not pursued for this application, but other sigma antagonists continue to be researched for a variety of potential applications.[4] Rimcazole has been shown to reduce the effects of cocaine,[5] and analogues of rimcazole have been shown to be highly effective at blocking the convulsions caused by cocaine overdose in animal models.[6]
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
| This biochemistry article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)